Pfizer reduces COVID-19 vaccine doses from 100 to 50 million due to ‘production quality issues’



[ad_1]

Pharmaceutical giant Pfizer now expects to ship only half of its originally planned COVID-19 vaccines by the end of this year due to supply chain problems.

A company spokesperson tells the Wall Street Journal that strengthening the supply chain of raw materials took longer than expected.

Pfizer and its Germany-based partner hoped to launch 100 million vaccines worldwide by December 31; that plan has now been reduced to 50 million.

The company still plans to ship more than one billion doses in 2021.

In mid-November, Ontario Health Minister Christine Elliott said so Canada is expected to receive millions of doses in the coming months.

The country is expected to receive four million doses of Pfizer’s vaccine and two million doses of Moderna between January and March.

Subsequently, Elliott said Ontario will receive approximately 1.6 million doses of Pfizer’s vaccine and approximately 800,000 of Moderna for proper distribution.

On Wednesday, Pfizer and BioNTech obtained permission for the emergency use of their COVID-19 vaccine in Britain. The move allowed Britain become one of the first countries to start vaccinating its population.

In a series of tweets, Canadian health minister Patty Hajdu described the UK’s decision to authorize Pfizer’s vaccine as “encouraging”.

The federal government suffered criticism of vaccines since Prime Minister Justin Trudeau admitted last week that other countries with domestic vaccine production are likely to inoculate their citizens before they ship doses to Canada.

[ad_2]
Source link